XML 67 R46.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Significant Accounting Policies - Additional Information (Detail) - USD ($) | 12 Months Ended |
--- | --- | ---
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Freezing amount in cash resulted from court pending legal action issued |  |  |  | $ 500,000
Advertising costs | $ 500,000 | $ 900,000 | $ 800,000 |
Musculoskeletal Transplant Foundation ("MTF") [Member] |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Expenditures for other research and development | 800,000 | 800,000 | 0 |
Neo Medical SA [Member] |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Expenditures for other research and development | 600,000 |  |  |
nView medical Inc [Member] |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Expenditures for other research and development | 0 |  |  |
Maximum [Member] |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Transactional foreign currency gains and (losses), including those generated from intercompany operations | $ (4,000,000.0) | 3,900,000 | $ (1,400,000) |
Maximum [Member] | Neo Medical SA [Member] |  |  |  |
Summary Of Significant Accounting Policies [Line Items] |  |  |  |
Expenditures for other research and development |  | $ 100,000 |  |

X
- Definition Freezing amount in cash resulted from court pending legal action issued. + References No definition available. + Details
Name: | ofix_FreezingAmountInCashResultedFromCourtPendingLegalActionIssued
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Summary of significant accounting policies. + References No definition available. + Details
Name: | ofix_SummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | ofix_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 720 -SubTopic 35 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848 + Details
Name: | us-gaap_AdvertisingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894 + Details
Name: | us-gaap_ForeignCurrencyTransactionGainLossRealized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of other research and development expense. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=ofix_MusculoskeletalTransplantFoundationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=ofix_NeoMedicalSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_OtherSignificantNoncashTransactionsByUniqueDescriptionAxis=ofix_NViewMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |